The Valuation of the pharmaceutical company Ferring-Léčiva, a.s

The thesis deals with the valuation of the Ferring-Léčiva, a.s.. The estimated value of the company refers to April 1, 2012. Financial analysis of the company, analysis of the macroeconomic environment and industry analysis are applied in the process of valuation. The methods which are applied for the company valuation are free cash flow to the firm and free cash flow to the equity. Both methods are applied with two-stage model. After delivery of the statement of the enterprise value the attention is focused on the comparison with the method based on the accounting property of the company which is based on difference of the total assets and liabilities of the firm